bluebird bio, Inc. Files 8-K for Material Agreement
| Field | Detail |
|---|---|
| Company | Bluebird Bio, Inc. |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, sec-filing
Related Tickers: BBIO
TL;DR
BBIO filed an 8-K for a material definitive agreement. Keep an eye on this.
AI Summary
On May 13, 2025, bluebird bio, Inc. entered into a Material Definitive Agreement. The filing also includes other events and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 455 Grand Union Boulevard, Somerville, Massachusetts.
Why It Matters
This 8-K filing indicates a significant contractual development for bluebird bio, Inc., which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's stock price.
Key Numbers
- 001-35966 — Commission File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- bluebird bio, Inc. (company) — Registrant
- May 13, 2025 (date) — Date of earliest event reported
- 455 Grand Union Boulevard, Somerville, Massachusetts (location) — Principal executive offices
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the Material Definitive Agreement filed by bluebird bio, Inc.?
The filing indicates the entry into a Material Definitive Agreement on May 13, 2025, but the specific details of the agreement are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 13, 2025.
Where are bluebird bio, Inc.'s principal executive offices located?
The principal executive offices are located at 455 Grand Union Boulevard, Somerville, Massachusetts.
In which state is bluebird bio, Inc. incorporated?
bluebird bio, Inc. is incorporated in Delaware.
What is the Commission File Number for bluebird bio, Inc.?
The Commission File Number for bluebird bio, Inc. is 001-35966.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding bluebird bio, Inc..